Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BANK OF AMERICA CORP /DE/BAC · Entity 2801 | Director | April 29, 2009 | May 01, 2009 |
| CVS HEALTH CorpCVS · Entity 2884 | Director · Non-Executive Chairman | April 03, 2011 | April 05, 2011 |
| FIVE BELOW, INCFIVE · Entity 3393 | Director | May 04, 2026 | May 06, 2026 |
| PJT Partners Inc.PJT · Entity 3655 | Director | September 16, 2026 | September 18, 2026 |
| YUM BRANDS INCYUM · Entity 3067 | Director | February 10, 2017 | February 13, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BANK OF AMERICA CORP /DE/
Report date April 29, 2009 · Filed May 01, 2009
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Unit PlanSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 27,616.64 |
Reported balance
After 2009-03-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2009-03-27 · Grant · Acquired 37.58 · Balance 27,616.64 F1: Reinvested Director Deferred Compensation and Stock Unit Plan dividend Equivalents. Director Deferred Compensation and Stock Unit Plan units may be settled in stock upon death or termination of service as a director. F2: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. |
| Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 31,130.07 |
Reported balance
After 2009-03-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2009-03-27 · Grant · Acquired 42.36 · Balance 31,130.07 F3: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. F2: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F4: Phantom stock units may be settled in cash upon death or termination of service as a director. |
| Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 49,563.25 |
Reported balance
After 2009-04-29 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2009-04-29 · Grant · Acquired 18,433.18 · Balance 49,563.25 F5: Stock units represent payment of the restricted stock portion of the annual Directors' compensation under the Bank of America Corporation Directors' Stock Plan in transactions exempt under Rule 16b-3. F4: Phantom stock units may be settled in cash upon death or termination of service as a director. |
| Common StockSEC Table I · non-derivative | Direct | 57,260 |
Reported balance
Holding disclosure · report date 2009-04-29 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 57,260 |
| Common StockSEC Table I · non-derivative | Indirectby Ryan Family Foundation | 1,175 |
Reported balance
Holding disclosure · report date 2009-04-29 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,175 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse Trust | 804 |
Reported balance
Holding disclosure · report date 2009-04-29 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 804 |
Filing footnotes · ownership attribution and instrument terms
F1: Reinvested Director Deferred Compensation and Stock Unit Plan dividend Equivalents. Director Deferred Compensation and Stock Unit Plan units may be settled in stock upon death or termination of service as a director.
F2: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director.
F3: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director.
F4: Phantom stock units may be settled in cash upon death or termination of service as a director.
F5: Stock units represent payment of the restricted stock portion of the annual Directors' compensation under the Bank of America Corporation Directors' Stock Plan in transactions exempt under Rule 16b-3.
CVS HEALTH Corp
Report date April 03, 2011 · Filed April 05, 2011
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Trust As Beneficiary | 505,743 |
Reported balance
After 2011-01-07 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2011-01-07 · Gift · Disposed 11,150 · Balance 505,743 |
| Common StockSEC Table I · non-derivative | Direct | 1,156,701.9341 |
Reported balance
After 2011-04-03 transaction · row 2
1 source rowRow 2 · 2011-04-03 · Tax withholding · Disposed 27,468 · Balance 1,156,701.9341 F1: Surrender of shares in payment of withholding taxes due. |
| Common StockSEC Table I · non-derivative | IndirectBy Foundation | 67,040 |
Reported balance
Holding disclosure · report date 2011-04-03 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 67,040 |
| Common Stock (restricted)SEC Table I · non-derivative | Direct | 481,337.4102 |
Reported balance
Holding disclosure · report date 2011-04-03 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 481,337.4102 |
| ESOP Common StockSEC Table I · non-derivative | IndirectBy ESOP | 8,322.4199 |
Reported balance
Holding disclosure · report date 2011-04-03 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 8,322.4199 |
| Stock UnitSEC Table I · non-derivative | Direct | 1,086,391.5831 |
Reported balance
Holding disclosure · report date 2011-04-03 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 1,086,391.5831 |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of withholding taxes due.
FIVE BELOW, INC
Report date May 04, 2026 · Filed May 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 119,030 |
Reported balance
After 2026-05-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-04 · Grant · Acquired 96 · Balance 119,030 F1: The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer payment of $22,500.00, less applicable tax withholdings. F2: Includes shares held by the reporting person's revocable trust. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were issued to the reporting person pursuant to the Five Below, Inc. Compensation Policy for Non-Employee Directors in lieu of a quarterly retainer payment of $22,500.00, less applicable tax withholdings.
F2: Includes shares held by the reporting person's revocable trust.
PJT Partners Inc.
Report date September 16, 2026 · Filed September 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 11,940 |
Reported balance
After 2026-09-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-16 · Grant · Acquired 19 · Balance 11,940 F1: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock. F2: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A common stock.
F2: Represents dividend equivalent rights in connection with the Issuer's dividend that accrue to the reporting person in restricted stock units that vest at the same time(s) as the underlying restricted stock units.
YUM BRANDS INC
Report date February 10, 2017 · Filed February 13, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,749 |
Reported balance
After 2017-02-10 transaction · row 1
1 source rowRow 1 · 2017-02-10 · Grant · Acquired 3,749 · Balance 3,749 |
| Common StockSEC Table I · non-derivative | IndirectRyan Trust | 38,706 |
Reported balance
Holding disclosure · report date 2017-02-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 38,706 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 8,500 | $37.52 | $318,920.00 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 14 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,273 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 15, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 27,561 | $37.51 | $1,033,813.11 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 13 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,773 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 15, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 43,400 | $37.50 | $1,627,500.00 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 12 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,334 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 15, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 101,261 | $18.35 | $1,857,906.45 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 11 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 553,734 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 14, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 290,059 | $0.00 Strike: $18.35 | $0.00 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · derivative · entry 37 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,261 Underlying: Common Stock · 290,059 shares Expires 2008-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Option became exercisable in three annual installments, commencing 02/27/01. Read SEC document |
| August 14, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 5,700 | $37.57 | $214,149.00 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 10 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,473 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 14, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 1,000 | $37.57 | $37,565.00 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 9 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 458,173 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 14, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 20,100 | $37.56 | $754,956.00 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 8 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,173 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 14, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 46,337 | $37.55 | $1,739,954.35 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 7 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 479,273 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 14, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 66,911 | $37.54 | $2,511,838.94 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 6 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 525,610 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 14, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 21,400 | $37.53 | $803,142.00 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 5 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 592,521 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 14, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 21,410 | $37.52 | $803,303.20 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 4 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 613,921 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 14, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 48,501 | $37.51 | $1,819,272.51 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 3 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 635,331 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 14, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 58,700 | $37.50 | $2,201,250.00 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 683,832 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| August 14, 2007 Filed Aug 16, 2007 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 290,059 | $18.35 | $5,321,915.51 |
DisclosureSEC source: 0000064803-07-000142 · doc.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 742,532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| June 22, 2007 Filed Nov 7, 2007 18:49 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantPhantom Stock · Derivative | 238.26 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-07-009716 · doc4.xml · derivative · entry 4 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,064.87 Underlying: Common Stock · 238.26 shares Expires not disclosed F3 · price: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. F3 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. F3 · derivative.expiration_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. Read SEC document |
| June 22, 2007 Filed Nov 7, 2007 18:49 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantDirector Stock Unit Plan · Derivative | 279.06 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-07-009716 · doc4.xml · derivative · entry 3 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,671.07 Underlying: Common Stock · 279.06 shares Expires not disclosed F2 · price: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F2 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F2 · derivative.expiration_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. Read SEC document |
| April 25, 2007 Filed Apr 27, 2007 13:52 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantPhantom Stock · Derivative | 5,075.15 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-07-004006 · doc4.xml · derivative · entry 6 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,826.61 Underlying: Common Stock · 5,075.15 shares Expires not disclosed F4 · shares: Shares represent payment of the annual Directors' compensation under the Bank of America Corporation Directors' Stock Plan in transactions exempt under Rule 16b-3. F5 · derivative.exercise_date: Phantom stock units may be settled in cash upon death or termination of service as a director. F5 · derivative.expiration_date: Phantom stock units may be settled in cash upon death or termination of service as a director. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 403,226 | $0.00 Strike: $34.42 | $0.00 |
DisclosureSEC source: 0000064803-07-000077 · doc.xml · derivative · entry 18 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,226 Underlying: Common Stock · 403,226 shares Expires 2014-04-02 F6 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/2/2008. Read SEC document |
| April 02, 2007 Filed Apr 4, 2007 21:23 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 117,097 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000077 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 975,274 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse in two equal installments on 4/2/2010 and 4/2/2012. Read SEC document |
| April 02, 2007 Filed Apr 18, 2007 20:18 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 116,212 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000086 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 974,389 F2 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse in two equal installments on 4/2/2010 and 4/2/2012. Read SEC document |
| March 23, 2007 Filed Apr 27, 2007 13:52 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantPhantom Stock · Derivative | 652.89 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-07-004006 · doc4.xml · derivative · entry 5 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,751.46 Underlying: Common Stock · 652.89 shares Expires not disclosed F1 · shares: Phantom stock units acquired between June 23, 2006 and March 23, 2007 with reinvested dividend equivalents under the Bank of America Director Stock Plan. F3 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. F3 · derivative.expiration_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in cash on death or termination of service as a director. Read SEC document |
| March 23, 2007 Filed Apr 27, 2007 13:52 UTC | BANK OF AMERICA CORP /DE/ BAC · Entity 2801 | GrantDirector Stock Unit Plan · Derivative | 1,011.03 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-07-004006 · doc4.xml · derivative · entry 4 RYAN THOMAS M · CIK 0001194416 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,392.01 Underlying: Common Stock · 1,011.03 shares Expires not disclosed F1 · shares: Phantom stock units acquired between June 23, 2006 and March 23, 2007 with reinvested dividend equivalents under the Bank of America Director Stock Plan. F2 · derivative.exercise_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. F2 · derivative.expiration_date: Reinvested Phantom Stock dividends which are exempt under Rule 16b-3. Phantom Stock units may be settled in stock on death or termination of service as a director. Read SEC document |
| February 12, 2007 Filed Feb 20, 2007 18:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 51,902 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000030 · doc.xml · nonDerivative · entry 3 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,192 F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| January 03, 2007 Filed Jan 5, 2007 21:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 57,843 | $30.93 | $1,788,794.78 |
DisclosureSEC source: 0000064803-07-000002 · doc.xml · nonDerivative · entry 3 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust as beneficiary Disclosed balance after: 975,571 F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| December 29, 2006 Filed Feb 9, 2007 19:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 1,550 | $31.08 | $48,166.25 |
DisclosureSEC source: 0000064803-07-000023 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,558 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 22, 2006 Filed Feb 9, 2007 19:46 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 32,280 | $31.46 | $1,015,367.40 |
DisclosureSEC source: 0000064803-07-000023 · doc.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,108 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 19, 2006 Filed Dec 19, 2006 21:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 78,264 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000064803-06-000048 · doc.xml · derivative · entry 11 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 78,264 shares Expires 2007-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 02/17/00. Read SEC document |
| December 19, 2006 Filed Dec 19, 2006 21:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 52,200 | $29.68 | $1,549,358.64 |
DisclosureSEC source: 0000064803-06-000048 · doc.xml · nonDerivative · entry 6 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,446 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $29.44 and $30.02 per share. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 19, 2006 Filed Dec 19, 2006 21:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 78,264 | $11.50 | $900,036.00 |
DisclosureSEC source: 0000064803-06-000048 · doc.xml · nonDerivative · entry 5 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 18, 2006 Filed Dec 19, 2006 21:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 78,264 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000064803-06-000048 · doc.xml · derivative · entry 10 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,264 Underlying: Common Stock · 78,264 shares Expires 2007-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 02/17/00. Read SEC document |
| December 18, 2006 Filed Dec 19, 2006 21:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 52,200 | $30.10 | $1,571,423.58 |
DisclosureSEC source: 0000064803-06-000048 · doc.xml · nonDerivative · entry 4 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,382 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $29.74 and $30.28 per share. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 18, 2006 Filed Dec 19, 2006 21:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 78,264 | $11.50 | $900,036.00 |
DisclosureSEC source: 0000064803-06-000048 · doc.xml · nonDerivative · entry 3 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 15, 2006 Filed Dec 19, 2006 21:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 78,264 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000064803-06-000048 · doc.xml · derivative · entry 9 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,528 Underlying: Common Stock · 78,264 shares Expires 2007-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 02/17/00. Read SEC document |
| December 15, 2006 Filed Dec 19, 2006 21:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 52,200 | $30.99 | $1,617,417.00 |
DisclosureSEC source: 0000064803-06-000048 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,318 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $30.51 and $31.43 per share. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 15, 2006 Filed Dec 19, 2006 21:41 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 78,264 | $11.50 | $900,036.00 |
DisclosureSEC source: 0000064803-06-000048 · doc.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 14, 2006 Filed Dec 15, 2006 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 78,264 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000064803-06-000047 · doc.xml · derivative · entry 8 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,792 Underlying: Common Stock · 78,264 shares Expires 2007-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 02/17/00. Read SEC document |
| December 14, 2006 Filed Dec 15, 2006 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 52,200 | $30.77 | $1,605,995.64 |
DisclosureSEC source: 0000064803-06-000047 · doc.xml · nonDerivative · entry 4 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,254 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $30.32 and $31.00 per share. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 14, 2006 Filed Dec 15, 2006 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 78,264 | $11.50 | $900,036.00 |
DisclosureSEC source: 0000064803-06-000047 · doc.xml · nonDerivative · entry 3 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 13, 2006 Filed Dec 15, 2006 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 78,264 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000064803-06-000047 · doc.xml · derivative · entry 7 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,056 Underlying: Common Stock · 78,264 shares Expires 2007-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 02/17/00. Read SEC document |
| December 13, 2006 Filed Dec 15, 2006 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 52,200 | $30.28 | $1,580,381.10 |
DisclosureSEC source: 0000064803-06-000047 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,190 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $30.06 and $30.48 per share. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 13, 2006 Filed Dec 15, 2006 20:55 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 78,264 | $11.50 | $900,036.00 |
DisclosureSEC source: 0000064803-06-000047 · doc.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 12, 2006 Filed Dec 13, 2006 19:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 78,264 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000064803-06-000046 · doc.xml · derivative · entry 8 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 391,320 Underlying: Common Stock · 78,264 shares Expires 2007-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 02/17/00. Read SEC document |
| December 12, 2006 Filed Dec 13, 2006 19:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 52,200 | $30.12 | $1,572,117.84 |
DisclosureSEC source: 0000064803-06-000046 · doc.xml · nonDerivative · entry 4 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,126 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $29.95 and $30.38 per share. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 12, 2006 Filed Dec 13, 2006 19:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 78,264 | $11.50 | $900,036.00 |
DisclosureSEC source: 0000064803-06-000046 · doc.xml · nonDerivative · entry 3 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 11, 2006 Filed Dec 13, 2006 19:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 78,264 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000064803-06-000046 · doc.xml · derivative · entry 7 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,584 Underlying: Common Stock · 78,264 shares Expires 2007-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 02/17/00. Read SEC document |
| December 11, 2006 Filed Dec 13, 2006 19:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 52,200 | $30.05 | $1,568,860.56 |
DisclosureSEC source: 0000064803-06-000046 · doc.xml · nonDerivative · entry 2 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,062 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $29.93 and $30.25 per share. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 11, 2006 Filed Dec 13, 2006 19:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 78,264 | $11.50 | $900,036.00 |
DisclosureSEC source: 0000064803-06-000046 · doc.xml · nonDerivative · entry 1 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 08, 2006 Filed Dec 8, 2006 21:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 78,264 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000064803-06-000045 · doc.xml · derivative · entry 11 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 547,848 Underlying: Common Stock · 78,264 shares Expires 2007-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 02/17/00. Read SEC document |
| December 08, 2006 Filed Dec 8, 2006 21:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 52,200 | $30.19 | $1,575,839.70 |
DisclosureSEC source: 0000064803-06-000045 · doc.xml · nonDerivative · entry 6 RYAN THOMAS M · CIK 0001194416 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,998 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $29.95 and $30.30 per share. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.